Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Kamugisha, Erasmus ^a   Jing, Sun ^b   Minde, Mercy ^a   Kataraihya, Johaness ^a   Kongola, Gilbert ^a   Kironde, Fred ^c   Swedberg, Göte ^b  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b UPPSALA UNIVERSITY   (Sweden)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

Mutations; pfatp6; pfcrt; pfdhfr; pfdhps; pfmdr1

Indexed keywords

ANTIINFECTIVE AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CHLOROQUINE; HEMOGLOBIN; PYRIMETAMINE; SULFADOXINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PARASITE ANTIGEN; PROTOZOAL DNA;

ALLELE; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL FEATURE; DNA DETERMINATION; DNA EXTRACTION; DRUG EFFICACY; DRUG RESISTANCE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANZANIA; TREATMENT OUTCOME; BLOOD; COHORT ANALYSIS; DNA FINGERPRINTING; DRUG COMBINATION; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; MISSENSE MUTATION; PARASITOLOGY; PROSPECTIVE STUDY;

ANTIGENS, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; BLOOD; CHILD, PRESCHOOL; COHORT STUDIES; DNA FINGERPRINTING; DNA, PROTOZOAN; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; FEMALE; FLUORENES; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFANT; MALARIA; MALE; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROSPECTIVE STUDIES; TANZANIA; TREATMENT OUTCOME;

EID: 84857408954     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-58     Document Type: Article

References (31)

1. WHO, WHO Malaria report Geneva: World Health Organization 2009
2. National Malaria Control Programme, Ministry of Health, Malaria treatment guidelines Dar es Salaam, Tanzania: Ministry of Health 2006
3. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydrofolate synthase mutations in monitoring in vivo resistance. Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H, Am J Trop Med Hyg 2004 71 696 702 15642957 (Pubitemid 40075616)
4. National Malaria Control Programme, Ministry of Health, Malaria treatment guidelines Dar es Salaam, Tanzania: Ministry of Health 2000
5. Changes in malaria indices between between 1999 and 2007 in the Gambia: a retrospective analysis. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ, Lancet 2008 372 1545 1554 10.1016/S0140-6736(08)61654-2 18984187
6. Effect of a fall in malaria transmission on morbidity and mortarity in Kilifi, Kenya. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K, Lancet 2008 372 1555 1562 10.1016/S0140-6736(08)61655-4 18984188
7. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
8. Efficacy and safety of artemether-lumefantrine (Co-artem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, De Pelacios PI, Trans R Soc Trop Med Hyg 2005 99 459 467 10.1016/j.trstmh.2004.09. 013 15837358 (Pubitemid 40521344)
9. Efficacy and safety of six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Pelacios PI, Am J Trop Med Hyg 2006 74 991 998 16760509 (Pubitemid 351627405)
10. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, DÁlessandro U, Rosenthal PJ, Talisuna AO, BMJ 2009 339 2763 10.1136/bmj.b2763 19622553
11. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non inferiority trial. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team, Lancet 2010 375 1457 1467 10.1016/S0140-6736(10)60322-4 20417857
12. Malaria genomics meets drug-resistance phenotyping in the field. Hunt P, Macinnis B, Roper C, Genome Biol 2009 10 314 10.1186/gb-2009-10-8-314 19664295
13. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, Nat Struct Mol Biol 2005 12 628 629 10.1038/nsmb947 15937493 (Pubitemid 40980816)
14. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type Pfatpase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O, Lancet 2005 366 2012 2018 10.1016/S0140-6736(05)67669-6 16338450 (Pubitemid 41773376)
15. Gene encoding a deubiquitinating enzyme is mutated in artesunate and chloroquine-resistant rodent malaria parasites. Hunt P, Afonso A, Creasey A, Culleton R, Sidhu AB, Logan J, Valderramos SG, McNae I, Cheesman S, do Rosario V, Carter R, Fidock DA, Cravo P, Mol Microbiol 2007 65 27 40 10.1111/j.1365-2958.2007.05753.x 17581118 (Pubitemid 46934481)
16. Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation. Wang J, Huang L, Li J, Fan O, Long Y, Li Y, Zhou B, PLoS One 2010 5 9582 10.1371/journal.pone.0009582 20221395
17. In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem). Sisowath C, Strömberg J, Mårtensson A, Msellem M, Obondo C, Björkman A, Gil JP, J Infect Dis 2005 191 1014 1017 10.1086/427997 15717281 (Pubitemid 40349821)
18. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, J infect Dis 2003 187 1870 1875 10.1086/375419 12792863 (Pubitemid 36724485)
19. Return of chloroquine antimalarial efficacy in Malawi. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, N Engl J Med 2006 355 19 1959 1966 10.1056/NEJMoa062032 17093247 (Pubitemid 44708015)
20. WHO, Assesment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated malaria WHO/HTM/RBM/2003.50
21. Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Bereczky S, Mårtenson A, Gil JP, Färnert A, Am J Trop Med Hyg 2005 72 249 251 15772315 (Pubitemid 41278870)
22. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
23. The Tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the antimalarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315 (Pubitemid 30236312)
24. Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Duraisingh MT, Curtis J, Warhurst D, Exp Parasitol 1998 89 1 8 10.1006/expr.1998.4274 9603482 (Pubitemid 28377366)
25. Detecting adenosine triphosphatase 6 (PfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda. Kamugisha E, Sendagire H, KadduMukasa M, Enweji N, Gheysari F, Swedberg G, Kironde F, Tanzan J Health Res 2011 13 50 60
26. The role of Pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Sisowath C, Ferreira P, Bustamante LY, Dahlström S, Mårtensson A, Björkman A, Krishna S, Gil JP, Trop Med Int Health 2007 12 736 742 10.1111/j.1365-3156.2007.01843.x 17550470 (Pubitemid 46872790)
27. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of malaria vaccine SPf66. Beck HP, Felger I, Huber W, Steiger S, Smith T, Weiss N, Alonso PL, Tanner M, J Infect Dis 1997 175 921 926 10.1086/513991 9086150 (Pubitemid 27142968)
28. Therapeutic efficacy of artemether/lumefantrine (Coartem) against Plasmodium falciparum in Kersa, South West Ethiopia. Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T, Parasit Vectors 2010 3 1 10.1186/1756-3305-3-1 20051120
29. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Björkman A, Mårtensson A, Clin Infect Dis 2011 52 873 882 10.1093/cid/cir066 21427394
30. Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Frosch AEP, Venkatesan M, Laufer MK, Malaria J 2011 10 116 10.1186/1475-2875-10-116
31. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon. Frank M, Lehners N, Mayengue PI, Gabor J, Dal-Bianco M, Kombila DU, Ngoma GM, Supan C, Lell B, Ntoumi F, Grobusch MP, Dietz K, Kremsner PG, Malar J 2011 10 304 10.1186/1475-2875-10-304 22004584